The Intranasal Drug Delivery Devices Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2024-2033).
Learn More On The Intranasal Drug Delivery Devices Market:
As per The Business Research Company’s Intranasal Drug Delivery Devices Global Market Report 2024, the market for intranasal drug delivery devices has exhibited robust growth in recent times, ascending from $55.27 billion in 2024 to $60.27 billion in 2024, denoting a notable compound annual growth rate (CAGR) of 9.0%. This growth trajectory in the historical period is attributable to several factors including the escalation of chronic respiratory ailments, heightened patient preference and compliance, the convenience associated with self-administration, burgeoning pediatric applications, and the expanded market presence in allergic rhinitis treatment, along with a broader spectrum of indications.
Projections for the future depict a continued upward trajectory, with the market poised to burgeon to $84.51 billion by 2028, registering a CAGR of 8.8%. This anticipated growth in the forecast period can be primarily ascribed to the burgeoning geriatric demographic, the surge in global respiratory afflictions, the diversification of applications into neurological disorders, the prevailing trend towards personalized medicine, proactive healthcare initiatives, and the penetration of emerging economies into the market landscape. Noteworthy trends anticipated in the forecast period encompass advancements in formulation technologies, a heightened focus on pediatric and geriatric applications, the proliferation of self-administration devices, the advent of nasal powder inhalers, and the integration of biologics and peptides.
The increasing prevalence of chronic diseases is expected to propel the growth of the intranasal drug delivery devices market going forward. Chronic diseases can be defined as conditions that last 1 year or more and require ongoing medical attention, limit activities of daily living, or both. Intranasal drug delivery devices are used to manage chronic diseases by providing a non-invasive and efficient way to administer medications. They allow medications to be delivered directly to the affected area, which is convenient, making it easy to use and promoting rapid absorption. For instance, in September 2022, according to a report published by the National Institutes of Health (NIH), a US-based biomedical research agency, in 2024, in the United States, the number of people aged 50 and older with at least one chronic illness is predicted to rise by 99.5%, from 71.522 million in 2020 to 142.66 million in 2050. Additionally, the number of people with multimorbidity would rise by 91.16% from 7.8304 million in 2020 to 14.968 million in 2050. Therefore, the increasing prevalence of chronic diseases is driving the growth of the intranasal drug delivery devices market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=13463&type=smp
The intranasal drug delivery devices market covered in this report is segmented –
1) By Product: Powder Delivery Device, Liquid Delivery Device, Pressurized Metered-Dose Inhalers, Other Products
2) By Dosage: Unit-Dose, Multi-Dose
3) By Application: Chronic Obstructive Pulmonary Disease (COPD), Rhinitis, Cystic Fibrosis, Nasal Congestion, Asthma, Other Applications
4) By End User: Hospitals, Clinics, Homecare, Other End Users
Prominent pharmaceutical entities operating within the nasal drug delivery technology arena are actively engaged in the development of novel and enhanced products, aiming to furnish their clientele with innovative means of drug administration to fortify their market positioning. A case in point is AptarGroup, Inc., a US-based enterprise specializing in drug delivery and pharmaceuticals, which recently introduced APF Futurity, the inaugural recyclable, metal-free, multidose nasal spray. Designed to dispense nasal saline and equivalent over-the-counter (OTC) formulations, APF Futurity is crafted from polyolefin materials, devoid of any metal constituents or recycling disruptors. This innovative design not only reduces the need for segregation in recycling streams but also fosters a higher grade of recycled materials. Notably, APF Futurity has garnered Class AA certification from cyclos-HTP for recycling streams in Europe, owing to its highly recyclable nasal spray pump design, thus exemplifying a commitment towards sustainability and environmental stewardship.
The intranasal drug delivery devices market report table of contents includes:
1. Executive Summary
2. Intranasal Drug Delivery Devices Market Characteristics
3. Intranasal Drug Delivery Devices Market Trends And Strategies
4. Intranasal Drug Delivery Devices Market - Macro Economic Scenario
5. Global Intranasal Drug Delivery Devices Market Size and Growth
.....
32. Global Intranasal Drug Delivery Devices Market Competitive Benchmarking
33. Global Intranasal Drug Delivery Devices Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Intranasal Drug Delivery Devices Market
35. Intranasal Drug Delivery Devices Market Future Outlook and Potential Analysis
36. Appendix
Related Reports:
https://topprnews.com/sports-coaching-platforms-market-size/
https://topprnews.com/spring-and-wire-products-market-size/
https://topprnews.com/stainless-steel-market-size/
https://goodprnews.com/sports-coaching-platforms-market-size/
https://goodprnews.com/spring-and-wire-products-market-size/
https://goodprnews.com/stainless-steel-market-size/
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
The report gives a clear image of the current Intranasal Drug Delivery Devices Market scenario and the expected future of the industry.
Besides, the report also represents the market performance by value chain analysis which will help to provide better product differentiation along with the analysis of each segment regarding opportunity, market attractiveness index and growth rate.
According to this study, over the next five years the Intranasal Drug Delivery Devices market will register a 10.8% CAGR in terms of revenue, the global market size will reach US$ 1269.8 million by 2024, from US$ 842.9 million in 2019.
In particular, this report presents the global market share (sales and revenue) of key companies in Intranasal Drug Delivery Devices business, shared in Chapter 3.
Browse the complete Intranasal Drug Delivery Devices market Report and TOC @ https://www.decisiondatabases.com/ip/40765-intranasal-drug-delivery-devices-market-analysis-report The key manufacturers covered in this report: BDAptarGroupTeleflexH＆T Presspart3MBespak Segmentation by product type: MultidoseUni/bidose Segmentation by application: Personal UseHospital Use This report also splits the market by region: AmericasUnited StatesCanadaMexicoBrazilAPACChinaJapan…….
Download Free Sample Report of Global Intranasal Drug Delivery Devices Market Report @ https://www.decisiondatabases.com/contact/download-sample-40765 Research objectives To study and analyze the global Intranasal Drug Delivery Devices consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.To understand the structure of Intranasal Drug Delivery Devices market by identifying its various subsegments.Focuses on the key global Intranasal Drug Delivery Devices manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.To analyze the Intranasal Drug Delivery Devices with respect to individual growth trends, future prospects, and their contribution to the total market.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).To project the consumption of Intranasal Drug Delivery Devices submarkets, with respect to key regions (along with their respective key countries).To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.To strategically profile the key players and comprehensively analyze their growth strategies.
Intranasal Drug Delivery Devices-Global Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Intranasal Drug Delivery Devices industry, standing on the readers’ perspective, delivering detailed market data and penetrating insights.
No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information.
Key questions answered by this report include:Worldwide and Regional Market Size of Intranasal Drug Delivery Devices 2013-2017, and development forecast 2018-2023Request a sample of this report @ https://www.orbisresearch.com/contacts/request-sample/2846472 Main manufacturers/suppliers of Intranasal Drug Delivery Devices worldwide, with company and product introduction, position in the Intranasal Drug Delivery Devices marketMarket status and development trend of Intranasal Drug Delivery Devices by types and applicationsCost and profit status of Intranasal Drug Delivery Devices, and marketing statusMarket growth drivers and challengesThe report segments the global Intranasal Drug Delivery Devices market as:Global Intranasal Drug Delivery Devices Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):North AmericaEuropeChinaJapanRest APACLatin AmericaGlobal Intranasal Drug Delivery Devices Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):MultidoseUni/bidoseBrowse the complete report @ https://www.orbisresearch.com/reports/index/intranasal-drug-delivery-devices-global-market-status-and-trend-report-2013-2023Global Intranasal Drug Delivery Devices Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)Personal UseHospital UseGlobal Intranasal Drug Delivery Devices Market: Manufacturers Segment Analysis (Company and Product introduction, Intranasal Drug Delivery Devices Sales Volume, Revenue, Price and Gross Margin):AesculapAptarGroup3MTeleflexH T PresspartBespakBaxterNiproOmpi Stevanato GroupWeigaoUnilifeRoselabsVetter PharmaNational Medical ProductsRobert Bosch GmbHOwen MumfordYpsomedSHL GroupBespakROVI CMIn a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.Place a purchase order of this report @ https://www.orbisresearch.com/contact/purchase-single-user/2846472About Us:Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements.
We have vast database of reports from the leading publishers and authors across the globe.
We specialize in delivering customized reports as per the requirements of our clients.
We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization.
